Mostrando 8 resultados de: 8
Filtros aplicados
Subtipo de publicación
Article(8)
Publisher
Journal of Antimicrobial Chemotherapy(1)
Journal of Clinical Microbiology(1)
Medicina(1)
Molecules(1)
Nature Communications(1)
Área temáticas
Enfermedades(8)
Microorganismos, hongos y algas(8)
Farmacología y terapéutica(3)
Fisiología humana(1)
Ganadería(1)
Origen
scopus(8)
A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate
ArticleAbstract: Objectives: To determine the efficacy and the immunomodulatory function of Z-100 alone or combined wPalabras claves:IL-10, IL-4, L. amazonensisAutores:Hashiguchi Y., Jorge Diego Marco, Kato H., Korenaga M., Manuel H. Calvopina, Paola Andrea BarrosoFuentes:scopusEfficacy of topical treatment with (-)-epigallocatechin gallate, a green tea catechin, in mice with cutaneous leishmaniasis
ArticleAbstract: The treatment of leishmaniasis includes pentavalent antimony drugs but, because of the side effects,Palabras claves:(-)-epigallocatechin gallate, Cutaneous leishmaniasis, Green tea catechins, Leishmania (L.) amazonensisAutores:Álvarez A.M., Bracamonte E., Jorge Diego Marco, Korenaga M., Paola Andrea Barroso, Sosa A.M.Fuentes:scopusEfficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis
ArticleAbstract: Activation of innate immunity using adjuvants that activate Toll-like receptor 4 pathways have greatPalabras claves:Adjuvants, leishmaniasis, ONO-4007, VaccineAutores:Hashiguchi Y., Jorge Diego Marco, Korenaga M., Manuel H. Calvopina, Nonaka S., Paola Andrea Barroso, Philip John CooperFuentes:scopusNext-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
ArticleAbstract: Chagas Disease, caused by the protozoan Trypanosoma cruzi, is a major health and economic problem inPalabras claves:Autores:Agüero F., Altcheh J., Bracamonte E., Buscaglia C.A., Carmona S.J., Jorge Diego Marco, Mucci J., Nielsen M., Volcovich R.Fuentes:scopusHigh performance of an enzyme linked immunosorbent assay for American tegumentary leishmaniasis diagnosis with Leishmania (Viannia) braziliensis amastigotes membrane crude antigens
ArticleAbstract: The diagnosis of American tegumentary leishmaniasis (ATL) still requires the design of more effectivPalabras claves:Autores:Acuña L., Álvarez A.M., Basombŕo M.A., Bracamonte M.E., Cajal S.P., Carlos Lorenzo Hoyos, Diosque P., Hashiguchi Y., Jorge Diego Marco, Juarez M., Korenaga M., Lauthier J.J., Nasser J.R., Paola Andrea Barroso, Sánchez-Valdéz F.J., Sosa A.M., Uncos R.E.Fuentes:scopusRecombinant cysteine proteinase B from leishmania braziliensis and its domains: Promising antigens for serodiagnosis of cutaneous and visceral leishmaniasis in dogs
ArticleAbstract: Leishmaniasis represents a group of parasitic diseases caused by a protozoan of the genus LeishmaniaPalabras claves:Canine leishmaniasis serodiagnosis, Cysteine proteinase B, Leishmania braziliensisAutores:Alberti A.S., Basombŕo M.A., Bivona A.E., Cazorla S.I., Cerny N., Czentner L., Estévez O., Jorge Diego Marco, Landaburu A.C.C., Malchiodi E.L., Nevot C.Fuentes:scopusRole of three ELISA tests using promastigote homogenates of leishmania braziliensis, l. amazonensis and l. guyanensis in the diagnosis of tegumentary leishmaniasis
ArticleAbstract: It is important to know whether the variability of species of Leishmania parasites circulating in aPalabras claves:diagnostic, Elisa, leishmaniasisAutores:Cajal S.P., Carlos Lorenzo Hoyos, Cimino R.O., Gil J.F., Jorge Diego Marco, Juarez M., Krolewiecki A.J., María Celia Mora, María Fernanda García Bustos, Nasser J.R., Quiroga I.L.Fuentes:scopusThe Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
ArticleAbstract: During an infection the immune system produces pathogen-specific antibodies. These antibody repertoiPalabras claves:Autores:Agüero F., Altcheh J., Ballering G.E., Bracco L., Jorge Diego Marco, Kesper N., Lynn M.K., Marcipar I.S., Nolan M.S., Ramsey J.M., Ricci A.D., Salas-Sarduy E., Torrico F., Villar J.C.Fuentes:scopus